Interpace Biosciences Inc EV/EBITDA
What is the EV/EBITDA of Interpace Biosciences Inc?
The EV/EBITDA of Interpace Biosciences Inc is N/A
What is the definition of EV/EBITDA?
EV/EBITDA is enterprise value divided by earnings before interest, tax, depreciation, and amortization. It is a measure of how expensive a stock is and is more frequently valid for comparisons across companies than the price to earnings ratio. It measures the price (in the form of enterprise value) an investor pays for the benefit of the company’s cash flow (in the form of EBITDA).
= enterprise value / EBITDA
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA of companies in the Health Care sector on NASDAQ compared to Interpace Biosciences Inc
What does Interpace Biosciences Inc do?
advancing patient care through molecular diagnostic testing. interpace diagnostics develops molecular diagnostic tests. our molecular diagnostic tests provide unparalleled accuracy and clarity to improve outcomes in patients facing a cancer diagnosis. you can be assured that all of the molecular tests we offer are driven by rigorous, validated science. we power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. the unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.
Companies with ev/ebitda similar to Interpace Biosciences Inc
- Flying Service has EV/EBITDA of N/A
- Cinda International has EV/EBITDA of N/A
- Applied Molecular Transport has EV/EBITDA of N/A
- BAIC Motor has EV/EBITDA of N/A
- Dickson Concepts (International) has EV/EBITDA of N/A
- JB&ZJMY Co has EV/EBITDA of N/A
- Interpace Biosciences Inc has EV/EBITDA of N/A
- Adial Pharmaceuticals has EV/EBITDA of N/A
- PlantX Life has EV/EBITDA of N/A
- Axios Mobile Assets has EV/EBITDA of N/A
- Amira Nature Foods has EV/EBITDA of N/A
- Chromatic India has EV/EBITDA of N/A
- Mvp Hldgs Inc New has EV/EBITDA of N/A